Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Put/Call Ratio
Increase
Decrease
Funds Holding
2,561
Funds Holding Change
+22
Funds Holding Growth
+0.9%
Value
$875B
Holding in Top 10
1,128
Top 10 Change
+25
Top 10 Growth
+2%
Value Growth
+0.4%
New
90
Increased
1,152
Reduced
1,173
Closed
56
Capital Inflow
$36B
Capital Outflow
$35.4B
Net Capital Flow
+$649M
Capital Flow Change
-$6.85B
Calls
$9.5B
Puts
$9.54B
Net Calls
-$46.5M
Put/Call Ratio
1